Literature DB >> 21321334

The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm.

P Schwingenschuh1, P Katschnig, M J Edwards, J T H Teo, L V P Korlipara, J C Rothwell, K P Bhatia.   

Abstract

BACKGROUND: Psychogenic blepharospasm is difficult to distinguish clinically from benign essential blepharospasm (BEB). The blink reflex recovery cycle measures the excitability of human brainstem interneurons and is abnormal in BEB. We wished to study the blink reflex recovery cycle in patients with atypical (presumed psychogenic) blepharospasm (AB).
METHODS: This was a prospective data collection study investigating the R2 blink reflex recovery cycle at interstimulus intervals (ISI) of 200, 300, 500, 1,000, and 3,000 msec in 10 patients with BEB, 9 patients with AB, and 9 healthy controls. All patients had spasm of the orbicularis oculi muscles. To compare individual patients, an R2 recovery index was calculated as average of the recovery values at ISIs of 200, 300, and 500 msec, with the upper limit of normal defined as mean (control group) + 2 SD.
RESULTS: The R2 recovery cycle was significantly disinhibited in patients with BEB, whereas patients with AB did not differ from controls on a group level. The upper limit of normal for the R2 recovery index was 61%. The R2 index was abnormal in 9 out of 10 patients with BEB and in none of the patients with AB.
CONCLUSIONS: A normal blink reflex recovery cycle indicates normal brainstem interneuron excitability. Assessment of the R2 recovery cycle may provide a useful diagnostic tool to distinguish patients with psychogenic blepharospasm from BEB and is worthy of further study.

Entities:  

Mesh:

Year:  2011        PMID: 21321334      PMCID: PMC3053342          DOI: 10.1212/WNL.0b013e31820c3074

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  Blepharospasm: recent advances.

Authors:  Mark Hallett
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

2.  Cortical and spinal abnormalities in psychogenic dystonia.

Authors:  Alberto J Espay; Francesca Morgante; Jamie Purzner; Carolyn A Gunraj; Anthony E Lang; Robert Chen
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

3.  Blepharospasm and the modulation of cortical excitability in primary and secondary motor areas.

Authors:  G Kranz; E A Shamim; P T Lin; G S Kranz; B Voller; M Hallett
Journal:  Neurology       Date:  2009-12-08       Impact factor: 9.910

4.  Management of spasticity associated pain with botulinum toxin A.

Authors:  J Wissel; J Müller; J Dressnandt; F Heinen; M Naumann; H Topka; W Poewe
Journal:  J Pain Symptom Manage       Date:  2000-07       Impact factor: 3.612

5.  Blink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis.

Authors:  E Tolosa; L Montserrat; A Bayes
Journal:  Mov Disord       Date:  1988       Impact factor: 10.338

6.  Psychogenic myoclonus.

Authors:  K Monday; J Jankovic
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

7.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Psychogenic movement disorders: frequency, clinical profile, and characteristics.

Authors:  S A Factor; G D Podskalny; E S Molho
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

9.  Psychogenic parkinsonism.

Authors:  A E Lang; W C Koller; S Fahn
Journal:  Arch Neurol       Date:  1995-08

10.  Motor persistence of orbicularis oculi muscle in eyelid-opening disorders.

Authors:  M Aramideh; B W Ongerboer de Visser; J H Koelman; J D Speelman
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

View more
  29 in total

Review 1.  Functional neurological disorders: mechanisms and treatment.

Authors:  Alexander Lehn; Jeannette Gelauff; Ingrid Hoeritzauer; Lea Ludwig; Laura McWhirter; Stevie Williams; Paula Gardiner; Alan Carson; Jon Stone
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

Review 2.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

3.  INCREASED BLINKING MAY BE A PRECURSOR OF BLEPHAROSPASM: A LONGITUDINAL STUDY.

Authors:  Antonella Conte; Gina Ferrazzano; Giovanni Defazio; Giovanni Fabbrini; Mark Hallett; Alfredo Berardelli
Journal:  Mov Disord Clin Pract       Date:  2017-06-02

Review 4.  Delineating the electrophysiological signature of dystonia.

Authors:  Anna Latorre; Lorenzo Rocchi; Kailash P Bhatia
Journal:  Exp Brain Res       Date:  2020-07-25       Impact factor: 1.972

Review 5.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

6.  The role of the trigeminal sensory nuclear complex in the pathophysiology of craniocervical dystonia.

Authors:  Lynley Bradnam; Christine Barry
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

Review 7.  An update on psychogenic movement disorders.

Authors:  Aviva Ellenstein; Sarah M Kranick; Mark Hallett
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

8.  Long-term depression-like plasticity of the blink reflex for the treatment of blepharospasm.

Authors:  Gottfried Kranz; Ejaz A Shamim; Peter T Lin; George S Kranz; Mark Hallett
Journal:  Mov Disord       Date:  2013-02-11       Impact factor: 10.338

9.  Is increased blinking a form of blepharospasm?

Authors:  Antonella Conte; Giovanni Defazio; Gina Ferrazzano; Mark Hallett; Antonella Macerollo; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Neurology       Date:  2013-06-11       Impact factor: 9.910

10.  Abnormalities of Masseteric Inhibitory Reflex in Hereditary Geniospasm: Evidence for a Brainstem Myoclonus.

Authors:  Antonella Macerollo; Tabish A Saifee; Panagiotis Kassavetis; Giovanna Pilurzi; Susanne A Schneider; Mark J Edwards; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.